GLP-1 drugs can ‘reverse biologic aging’ by two to three years
Weight loss drugs may do more than melt away pounds — they could melt away years. Pharmaceutical companies…
Biological age test to steer GLP-1 prescriptions
Deep Longevity’s new US telehealth platform, Accrua, ties treatment plans to a blood-based aging score and re-tests every…
GLP-1s linked to a gross side effect in nails: study
Ozempic and Mounjaro can cost an arm and a leg — and maybe a fingernail. A new study…
Can GLP-1 drugs help stop compulsive shopping, gambling and other ways people throw away their money?
A growing body of research suggests GLP-1 drugs can do more than just help people lose weight by…
Study finds sharp increase in GLP-1 use among children ages 8 to 11
While it is still relatively rare for young children to be prescribed GLP-1 medications, researchers say their use…
A New King of The GLP-1s Could Be Crowned – Cardiac Wire
A New King of The GLP-1s Could Be Crowned Cardiac Wire‘Godzilla’ of weight-loss drugs could provide other important health…
GLP-1 use skyrocketed 24x in a key demographic
This year, the number of US adults on a GLP-1 medication for weight loss reached an astonishing 11%…
New weight-loss drug targets belly fat and can give ‘flatter stomach’ in weeks
Could a new drug that makes fat cells self-destruct be the next big GLP-1? CBL-514 targets fat cells,…
#EASD26: Regeneron’s antibody helps patients regain muscle after stopping GLP-1 therapy – Endpoints News
#EASD26: Regeneron’s antibody helps patients regain muscle after stopping GLP-1 therapy Endpoints NewsRegeneron weight-loss drug halves muscle loss in…
Dad says he went permanently blind — in lawsuit against Ozempic makers
Edward Gillen, 59, woke up one May morning last year and noticed a speck in his eye. The…
Doctors condemn Eli Lilly move to dispense GLP-1 medication Mounjaro direct to door
A move by a multi-billion-dollar global pharmaceutical company to bypass bricks and mortar pharmacies and deliver its GLP-1…
Roche cans muscle-preserving obesity drug, hands it back to Chugai
Roche has scrapped development of a muscle-building drug, ending a trial testing the experimental medicine in combination with…